

Is Angeliq 0.25/0.5 28 Day in shortage in 2026? Get the latest update on availability, pricing, and what to do if you can't find your medication.
If you depend on Angeliq 0.25/0.5 28 Day to manage your menopause symptoms, you may have noticed that finding it at your pharmacy has become more difficult. While Angeliq is not currently listed on the FDA's official drug shortage list, many patients across the country are reporting trouble getting their prescriptions filled.
Here's what's really going on — and what you can do about it.
As of early 2026, Angeliq 0.25/0.5 is not in a formal FDA-reported shortage. Bayer Healthcare continues to manufacture and distribute the product. However, the reality on the ground is more complicated.
Many patients are experiencing what's sometimes called a "practical shortage" — the drug is technically available in the supply chain, but individual pharmacies don't stock it because it's a lower-volume brand-name product. When your pharmacist says "we can't get it," they usually mean their automated ordering system didn't flag it for restocking, not that it's disappeared from the market entirely.
Several factors are converging to make Angeliq 0.25/0.5 difficult to locate:
Angeliq remains a brand-name product without generic competition at the 0.25/0.5 strength, which keeps prices elevated:
For a full breakdown of savings options, see our guide on how to save money on Angeliq.
One significant development: a generic version of the higher-strength Angeliq (0.5/1 mg) was approved by the FDA in October 2025, manufactured by Novast Labs. While this doesn't directly help patients on the 0.25/0.5 strength, it does open up a conversation with your doctor:
Additionally, other combination HRT alternatives like Bijuva (Estradiol/Progesterone) continue to be available for women who need to switch.
Here are the most effective strategies for locating your medication:
While Angeliq 0.25/0.5 28 Day isn't in an official shortage, the practical reality for many women is that finding it takes extra effort. The combination of single-source manufacturing, no generic competition, and low pharmacy stocking priority creates a frustrating gap between supply and demand.
Don't let a supply issue become a treatment gap. If you're having trouble, use the resources in this article — and if all else fails, talk to your doctor about temporary alternatives so you're never without hormone replacement therapy when you need it.
For providers managing patients on Angeliq, see our provider-focused shortage update.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.